| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015173 Pyrrolopyridine inhibitors of kinases |
| 01/20/2011 | US20110015172 Pyrrolopyrazine inhibitors of kinases |
| 01/20/2011 | US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| 01/20/2011 | US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 01/20/2011 | US20110015059 Cyclic compound, its metal complex and modified metal complex |
| 01/20/2011 | US20110012092 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same |
| 01/20/2011 | DE102009033208A1 Aminopyridinderivate Aminopyridine |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2768505A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2767764A1 Heterocyclic compound and use thereof |
| 01/20/2011 | CA2767089A1 Pyrrolopyridine inhibitors of kinases |
| 01/19/2011 | EP2275423A1 Process for the synthesis of paliperidone |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274307A1 Bridged heterocyclic compounds and methods of use |
| 01/19/2011 | EP2274302A2 Compounds and compositions as itpkb inhibitors |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP2273882A1 Bioactive compounds for treatment of cancer and neurodegenerative diseases |
| 01/19/2011 | EP2086540B1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 01/19/2011 | EP2013209B1 Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists |
| 01/19/2011 | EP1904482B1 Indolylmaleimide derivatives |
| 01/19/2011 | EP1804791B1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN1976930B 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN101952988A Perylene semiconductors and methods of preparation and use thereof |
| 01/19/2011 | CN101952289A Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 01/19/2011 | CN101952288A Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 01/19/2011 | CN101952287A Protein kinase inhibitors and use thereof |
| 01/19/2011 | CN101952286A Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 01/19/2011 | CN101952285A Amino triazoles as PI3K inhibitors |
| 01/19/2011 | CN101952284A New tetracyclic compounds |
| 01/19/2011 | CN101952283A Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 01/19/2011 | CN101952274A Non-nucleoside reverse transcriptase inhibitors |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952255A Compounds for inhibiting KSP kinesin activity |
| 01/19/2011 | CN101951909A Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101948471A Refining process of tosufloxacin tosylate |
| 01/19/2011 | CN101948470A Application of phenanthroindolizidine alkaloid organic acid salt derivative in medicine |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872035 Angiotensin II antagonists |
| 01/18/2011 | US7872018 Compounds and methods for kinase modulation, and indications therefor |
| 01/18/2011 | US7872016 Method for treating skeletal disorders resulting from FGFR malfunction |
| 01/18/2011 | US7872014 Anaplastic lymphoma kinase modulators and methods of use |
| 01/18/2011 | US7872011 Inhibition of phosphoinositide 3-kinase β |
| 01/18/2011 | US7872002 Therapeutic pyrazoloquinoline derivatives |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2564201C Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/13/2011 | WO2011005759A2 Lonidamine analogues for fertility management |
| 01/13/2011 | WO2011005731A2 Process for making cgrp receptor antagonist |
| 01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
| 01/13/2011 | WO2011004639A1 Organic electroluminescent element, novel compound, lighting device and display device |
| 01/13/2011 | WO2011004610A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003362A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 01/13/2011 | WO2010107791A4 Pyrazinoisoquinoline compounds |
| 01/13/2011 | WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | US20110009635 Novel nitrogen-containing organic compounds usable as catalytic composition precursors |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009619 Polycyclic compound |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009441 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009406 Tetrahydro-1h-pyrrolo fused pyridones |
| 01/13/2011 | US20110009401 2-aza-bicyclo[2.2.1]heptane derivatives |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009398 p27 Protein Inducer |
| 01/13/2011 | US20110009394 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 01/13/2011 | US20110009390 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009384 Fused ring compounds as partial agonists of ppar-gamma |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009378 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| 01/13/2011 | US20110009366 Bicyclic pyrimidinones and uses thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110008288 Hepatitis c virus inhibitors |
| 01/13/2011 | US20110008255 Beta-amyloid pet imaging agents |
| 01/13/2011 | US20110006670 Organic electroluminescence element, new compound for the same, display device and lighting device using the same |
| 01/13/2011 | US20110006291 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device |
| 01/13/2011 | CA2767556A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | CA2767079A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | CA2766343A1 Platelet-activating factor receptor antagonists |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2272517A1 Ortho-condensed pyridine and pyrimidine derivatives ( e.g. purines ) as protein kinases inhibitors |
| 01/12/2011 | EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 01/12/2011 | EP2271645A1 Compounds and compositions as kinase inhibitors |
| 01/12/2011 | EP2271640A2 Piperidine derivatives as cgrp receptor antagonists |